KIAA1731 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.283000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.320800E-01
Normal-vs-Stage2
5.373000E-01
Normal-vs-Stage3
1.887030E-01
Normal-vs-Stage4
3.007200E-01
Stage1-vs-Stage2
5.146000E-01
Stage1-vs-Stage3
6.276300E-02
Stage1-vs-Stage4
2.248800E-01
Stage2-vs-Stage3
1.654240E-01
Stage2-vs-Stage4
4.299400E-01
Stage3-vs-Stage4
5.821800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.309400E-01
Normal-vs-AfricanAmerican
6.236400E-01
Normal-vs-Asian
2.726600E-01
Caucasian-vs-AfricanAmerican
7.766400E-01
Caucasian-vs-Asian
9.960800E-01
AfricanAmerican-vs-Asian
7.391000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.146800E-01
Normal-vs-Female
1.919950E-01
Male-vs-Female
6.168600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.930000E-01
Normal-vs-Age(41-60Yrs)
6.400600E-01
Normal-vs-Age(61-80Yrs)
4.812800E-01
Normal-vs-Age(81-100Yrs)
5.362400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.652400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.476100E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.951400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.752000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.195800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.746600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.864830E-01
Normal-vs-Daily Drinker
3.558400E-01
Normal-vs-Weekly Drinker
4.687600E-01
Normal-vs-Occasional Drinker
4.310600E-01
Normal-vs-Social Drinker
6.310800E-01
Non Drinker-vs-Daily Drinker
6.204000E-01
Non Drinker-vs-Weekly Drinker
6.791200E-01
Non Drinker-vs-Occasional Drinker
3.212400E-01
Non Drinker-vs-Social Drinker
4.233000E-01
Daily Drinker-vs-Weekly Drinker
4.421600E-01
Daily Drinker-vs-Occasional Drinker
1.925790E-01
Daily Drinker-vs-Social Drinker
7.972600E-01
Weekly Drinker-vs-Occasional Drinker
6.817400E-01
Weekly Drinker-vs-Social Drinker
2.335600E-01
Occasional Drinker-vs-Social Drinker
7.867600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.269400E-01
Normal-vs-Grade 2
5.292500E-02
Normal-vs-Grade 3
7.116100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.352590E-01
Grade 1-vs-Grade 3
4.435800E-02
Grade 1-vs-Grade 4
2.269400E-01
Grade 2-vs-Grade 3
2.044600E-01
Grade 2-vs-Grade 4
5.292500E-02
Grade 3-vs-Grade 4
7.116100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.318600E-01
Normal-vs-NonDiabetic
5.574600E-01
Diabetic-vs-NonDiabetic
6.284000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.926200E-01
Normal-vs-NoPancreatitis
4.808800E-01
Pancreatitis-vs-NoPancreatitis
2.549600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.658200E-01
Normal-vs-N1
5.189400E-01
N0-vs-N1
5.166600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.765800E-01
Normal-vs-TP53-NonMutant
6.420800E-01
TP53-Mutant-vs-TP53-NonMutant
1.559840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
